+1-947-333-4405
+1-947-333-4405Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report
Mark A. Nelson is Professor of Pathology in University of Arizona.he completed his BS in Microbiology at Washington State University in 1984.In 1989 received PhD in Pharmacology/Toxicology from Washington State University.Expertise in Cancer Biology and Molecular Cell.His research career has been focused towards the molecular genetic studies on cancer (specifically solid tumors). The long-term goals of his research program are to identify genes involved in the etiology of cancers and to use the information from such studies to develop new and innovative treatments to prevent and cure cancers.
Inflammation and Cancer
• Cancer Etiology
• Cancer Chemoprevention and Treatment Target Identification
• Cancer Health Disparities"
The Implications of the BRCA Gene Patent Rulings for Individualized Medicine
| Mark A. Nelson |
| Editorial: J Clinic Experiment Pathol 2011, 1: e101 |
| DOI: 10.4172/2161-0681.1000e101 |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
